In a recent study, we already identified NFκB-related components of the SASP as major drivers of radioresistance and inhibition of the SASP by the senomorphic drug metformin was found to sensitize HNSCC tumor cells toward irradiation (9). This evidence concerns the gene NFKB1 and head and neck squamous cell carcinoma.